Gel Formulations with an Echinocandin for Cutaneous Candidiasis: The Influence of Azone and Transcutol on Biopharmaceutical Features

Gel Formulations with an Echinocandin for Cutaneous Candidiasis: The Influence of Azone and Transcutol on Biopharmaceutical Features

Caspofungin is a drug that is used for fungal infections that are difficult to treat, including invasive aspergillosis and candidemia, as well as other forms of invasive candidiasis. The aim of this study was to incorporate Azone in a caspofungin gel (CPF-AZ-gel) and compare it with a promoter-free...

Full description

Bibliographic Details
Main Authors:	Noelia Pérez-González, Lupe Carolina Espinoza, María Rincón, Lilian Sosa, Mireia Mallandrich, Joaquim Suñer-Carbó, Nuria Bozal-de Febrer, Ana Cristina Calpena, Beatriz Clares-Naveros
Format:	Article
Language:	English
Published:	MDPI AG 2023-04-01
Series:	Gels
Subjects:	caspofungin echinocandin Azone candidiasis permeation enhancer gel
Online Access:	https://www.mdpi.com/2310-2861/9/4/308

Similar Items

Retrospective cohort study comparing the risk of severe hepatotoxicity in hospitalized patients treated with echinocandins for invasive candidiasis in the presence of confounding by indication
by: Francis Vekeman, et al.
Published: (2018-08-01)

Cost-utility analysis of caspofungin and fluconazole for primary treatment of invasive candidiasis and candidemia in Ethiopia
by: Gebremedhin Beedemariam Gebretekle, et al.
Published: (2022-10-01)

Analysis of molecular resistance to azole and echinocandin in Candida species in patients with vulvovaginal candidiasis
by: Ensieh Lotfali, et al.
Published: (2022-06-01)

Recent Insights into the Paradoxical Effect of Echinocandins
by: Johannes Wagener, et al.
Published: (2017-12-01)

New Formulations Loading Caspofungin for Topical Therapy of Vulvovaginal Candidiasis
by: Noelia Pérez-González, et al.
Published: (2021-12-01)

Antifungal effects of echinocandins diminish when exposed to intestinal lumen contents: a finding with potentially significant clinical implications
by: Sepideh Mehravar, et al.
Published: (2024-03-01)

Candida spp. with Acquired Echinocandin Resistance, France, 2004–2010
by: Eric Dannaoui, et al.
Published: (2012-01-01)

Susceptibility testing of Candida glabrata clinical strains to echinocandins using SensititreTM YeastOneTM system
by: Veselov A.V., et al.
Published: (2018-02-01)

Candida glabrata Resistance to Echinocandins Associated with FKS Genes Mutations: How Urgent is the Problem?
by: Veselov A.V.
Published: (2016-05-01)

Stress-Induced Changes in the Lipid Microenvironment of β-(1,3)-<sc>d</sc>-Glucan Synthase Cause Clinically Important Echinocandin Resistance in <named-content content-type="genus-species">Aspergillus fumigatus</named-content>
by: Shruthi Satish, et al.
Published: (2019-06-01)

Susceptibility of the <i>Candida haemulonii</i> Complex to Echinocandins: Focus on Both Planktonic and Biofilm Life Styles and a Literature Review
by: Lívia S. Ramos, et al.
Published: (2020-10-01)

Pacemaker lead Candida endocarditis: Is medical treatment possible?
by: Syamasis Bandyopadhyay, et al.
Published: (2015-12-01)

Caspofungin-Loaded Formulations for Treating Ocular Infections Caused by <i>Candida</i> spp.
by: Noelia Pérez-González, et al.
Published: (2023-04-01)

Treatment of Invasive Candidiasis: A Narrative Review
by: Ronen Ben-Ami
Published: (2018-08-01)

Pharmacology and metabolism of anidulafungin, caspofungin and micafungin in the treatment of invasive candidosis - review of the literature
by: Kofla G, et al.
Published: (2011-04-01)

Review of the guidelines for the treatment and prevention of invasive candidiasis in newborns and children
by: Veselov A.V.
Published: (2017-05-01)

Pharmacoeconomic analysis of the anidulafungin (EraxisR) in adult patients with invasive candidiasis
by: S. V. Nedogoda, et al.
Published: (2019-10-01)

Caspofungin for treatment of invasive aspergillosis in Germany: results of a pre-planned subanalysis of an international registry
by: Egerer Gerlinde, et al.
Published: (2012-04-01)

Review on Current Status of Echinocandins Use
by: Martyna Mroczyńska, et al.
Published: (2020-05-01)

Biopharmaceutical Development of a Bifonazole Multiple Emulsion for Enhanced Epidermal Delivery
by: Joaquim Suñer-Carbó, et al.
Published: (2019-02-01)

Some issues of the resistance of Candida glabrata to echinocandins
by: Veselov A.V.
Published: (2019-12-01)

The in vitro Activity of Echinocandins Against Clinical Trichophyton rubrum Isolates and Review of the Susceptibility of T. rubrum to Echinocandins Worldwide
by: Su H, et al.
Published: (2023-08-01)

THE IMPACT OF ANTIFUNGALS ON TOLL-LIKE RECEPTORS
by: Mircea Radu Mihu, et al.
Published: (2014-03-01)

Results of treatment for candidemia in patients with blood system tumors
by: G A Kliasova, et al.
Published: (2013-11-01)

Post-Prescription Audit Plus Beta-D-Glucan Assessment Decrease Echinocandin Use in People with Suspected Invasive Candidiasis
by: Rita Murri, et al.
Published: (2021-06-01)

Necrotizing pancreatitis with invasive candidiasis and candidemia due to Candida albicans and pan-echinocandin-resistant Candida glabrata
by: Laman Rahimli, et al.
Published: (2024-03-01)

Modern approaches to the therapy of invasive mycoses in cancer patients
by: Aleksey O. Prikhodchenko, et al.
Published: (2021-08-01)

Efficacy of humanized single large doses of caspofungin on the lethality and fungal tissue burden in a deeply neutropenic murine model against Candida albicans and Candida dubliniensis
by: Prépost E, et al.
Published: (2019-07-01)

Pharmacokinetics of echinocandins in suspected candida peritonitis: A potential risk for resistance
by: Francesca Gioia, et al.
Published: (2020-12-01)

Experiencia con Acetato de Caspofungin en el tratamiento de Niños Neutropénicos Febriles con probable Micosis Sistémica, en el Hospital ION Solca Guayaquil
by: Aníbal Bonilla, et al.
Published: (2007-12-01)

Breakthrough invasive candidiasis in pediatric patient with Ewing’s sarcoma: dinical case report and literature review
by: Yu. V. Dinikina, et al.
Published: (2019-12-01)

INVASIVE MYCOSES IN INTENSIVE CARE UNITS
by: Yakubtsevich R. E.
Published: (2020-03-01)

Clinical characteristics of the first cases of invasive candidiasis in China due to pan-echinocandin-resistant Candida tropicalis and Candida glabrata isolates with delineation of their resistance mechanisms
by: Xiao M, et al.
Published: (2018-01-01)

Thermoreversible Gel-Loaded Amphotericin B for the Treatment of Dermal and Vaginal Candidiasis
by: Lilian Sosa, et al.
Published: (2019-07-01)

Efficacy and safety of triazoles versus echinocandins in the treatment of invasive aspergillosis: A meta-analysis
by: Uzelac Sanja M., et al.
Published: (2020-01-01)

Echinocandins – structure, mechanism of action and use in antifungal therapy
by: Mateusz Szymański, et al.
Published: (2022-12-01)

Successful management of recalcitrant fungal keratitis with topical caspofungin
by: Goel, Siddhi, et al.
Published: (2022-07-01)

Identification of Genes in Candida glabrata Conferring Altered Responses to Caspofungin, a Cell Wall Synthesis Inhibitor
by: Anne G. Rosenwald, et al.
Published: (2016-09-01)

Treatment of candidemia in a nationwide setting: increased survival with primary echinocandin treatment
by: Lausch KR, et al.
Published: (2018-11-01)

Two echinocandin-resistant Candida glabrata FKS mutants from South Africa
by: Serisha D. Naicker, et al.
Published: (2016-03-01)